Why AI and Doctors Should Drive Treatment, Not Insurers
A push for digital health records could shift clinical decisions away from insurers and toward physicians aided by AI diagnostic tools.
The debate over who controls American healthcare decisions is intensifying, and a growing chorus of clinicians and health-tech advocates are pointing toward a clear answer: the decision should belong to physicians and the artificial intelligence tools that support them — not insurance companies. The current system, in which insurers routinely approve or deny treatments through administrative processes far removed from the exam room, has long drawn criticism from medical professionals who argue it compromises patient outcomes.
At the center of the proposed shift is the digital health record — a comprehensive, interconnected ledger of a patient's full medical history. Unlike the fragmented records that define much of today's healthcare landscape, a robust digital record would give clinicians and AI-driven diagnostic tools a complete picture of a patient's health trajectory. The argument follows that better information leads to better decisions, and that AI can surface patterns across that data that even experienced physicians might miss under time pressure.
Read more Medicare Obesity Drug Coverage Starts July 1 — Awareness Gap Looms →
The implications of this vision extend well beyond technology adoption. If AI-assisted clinical tools become the authoritative voice in treatment planning, the role of insurance companies as de facto medical gatekeepers would be fundamentally challenged. Insurers have historically wielded significant influence through prior authorization requirements, which force doctors to justify treatments before coverage is granted — a process critics say delays care and prioritizes cost containment over medical necessity.
Of course, the transition is far from simple. Questions of data privacy, algorithmic bias, liability, and equitable access to advanced health technology remain largely unresolved. Handing more authority to AI systems requires a high degree of confidence in their accuracy and fairness across diverse patient populations — confidence that the medical and regulatory communities are still working to establish. The promise is real, but so are the obstacles standing between today's system and one where clinical intelligence, human or artificial, leads the way.
Continue reading at MarketWatch.com
